Eswara Reddy along with Animesh Kumar (Assistant Drugs Inspector), Biocon Biologics’ Associate Vice President L Praveen Kumar, and Synergy Network India Private Limited director Dinesh Dua, were arrested last year in the bribery case allegedly to waive the Phase 3 clinical trial of ‘Insulin Aspart’ injection, a product developed by the company to manage Type 1 and Type 2 diabetes. However, Biocon Biologics, a subsidiary of Kiran Mazumdar Shaw-led Biocon, denied the allegations of bribery.
